Hosted on MSN9d
Next-generation tau radiotracers outperform FDA-approved imaging agents in detecting Alzheimer's diseaseTwo new PET radiotracers have outperformed ... "In our study we tested three different tau radiotracers to determine how well ...
Two new PET radiotracers have outperformed the only currently Food and Drug Administration (FDA) approved radiotracer for ...
Positron Emission Tomography (PET) is a powerful imaging technique that allows for the visualization of metabolic processes in the body, particularly in the context of cancer. Recent research has ...
[3] FDG PET was more accurate than combined CI modalities for predicting outcome. Diseasefree survival was significantly different ... radiotracers have been studied. In patients with cervical ...
Fellows will also be exposed to advanced nuclear medicine techniques by way of multidisciplinary conferences, including brain PET with various ... radiotracers in neuroimaging including uses in ...
Though a majority of PET studies conducted within these populations have to date focused on β-amyloid, various 'nonamyloid ... nonamyloid PET radiotracers will prove of use, and, potentially ...
Two PSMA-positive tumors ... radiotracers and lack of an incident light source, resulting in high signal to background ratios. As well, multiple subjects may be imaged concurrently (up to 5 in common ...
Reston, VA (January 28, 2025)—Two new PET radiotracers ... three different tau radiotracers to determine how well they could discriminate late-stage Alzheimer’s disease brain tissue from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results